{
  "id": 15974540,
  "title": "Rezera files for IPO to back NLRP3 work in peripheral artery disease",
  "url": "https://urgent.news/2026/10/21/rezera-files-for-ipo-to-back-nlrp3-work-in-peripheral-artery-disease",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-21T23:45:38.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/rezera-files-for-ipo-to-back-nlrp3-work-in-peripheral-artery-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Rezera, the biotech that rebranded from NodThera earlier this year, has entered the queue for an initial public offering to bolster its decade-long NLRP3 efforts. The biotech submitted its pitch Wednesday ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}